2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone has been researched along with plumbagin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhasin, D; Chettiar, SN; Etter, JP; Li, PK; Mok, M | 1 |
Danilenko, NV; Karpenko, AS; Khlebnikov, AI; Kirpotina, LN; Levandovskiy, IA; Quinn, MT; Schepetkin, IA; Shibinska, MO | 1 |
2 other study(ies) available for 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and plumbagin
Article | Year |
---|---|
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Models, Molecular; Naphthoquinones; Structure-Activity Relationship | 2013 |
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
Topics: Antineoplastic Agents; cdc25 Phosphatases; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Humans; MAP Kinase Kinase 7; Models, Molecular; Molecular Docking Simulation; Naphthoquinones | 2019 |